Endeavor Biomedicines, Inc.
Clinical trials sponsored by Endeavor Biomedicines, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill aims to slow lung damage in scarring disease Results expected Oct 2026 (estimated)
- New lung drug ENV-101 put through safety checks in healthy volunteers Results expected Oct 2026 (estimated)